Literature DB >> 9853445

Prediction of cognitive decline in early Alzheimer's disease.

P M Doraiswamy, H C Charles, K R Krishnan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9853445     DOI: 10.1016/S0140-6736(05)61449-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  Recent advances in magnetic resonance neurospectroscopy.

Authors:  Yael Rosen; Robert E Lenkinski
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

2.  Indirect effects of elevated body mass index on memory performance through altered cerebral metabolite concentrations.

Authors:  Mitzi M Gonzales; Takashi Tarumi; Danielle E Eagan; Hirofumi Tanaka; Miral Vaghasia; Andreana P Haley
Journal:  Psychosom Med       Date:  2012-07-20       Impact factor: 4.312

3.  ¹H- and ¹³C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease.

Authors:  A Doert; U Pilatus; F Zanella; W E Müller; G P Eckert
Journal:  J Neural Transm (Vienna)       Date:  2015-03-06       Impact factor: 3.575

Review 4.  The prediction and prevention of Alzheimer's disease--towards a research agenda.

Authors:  R van Reekum; M Simard; T Cohen
Journal:  J Psychiatry Neurosci       Date:  1999-11       Impact factor: 6.186

Review 5.  Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Authors:  Y Y Hsu; A T Du; N Schuff; M W Weiner
Journal:  J Geriatr Psychiatry Neurol       Date:  2001       Impact factor: 2.680

6.  Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease.

Authors:  Madhav Thambisetty; Abdul Hye; Catherine Foy; Eileen Daly; Amanda Glover; Allison Cooper; Andrew Simmons; Declan Murphy; Simon Lovestone
Journal:  J Neurol       Date:  2008-08-01       Impact factor: 4.849

Review 7.  The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES).

Authors:  C C Gispen-de Wied; M Kritsidima; A J A Elferink
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

8.  1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease.

Authors:  Kejal Kantarci; Glenn E Smith; Robert J Ivnik; Ronald C Petersen; Bradley F Boeve; David S Knopman; Eric G Tangalos; Clifford R Jack
Journal:  J Int Neuropsychol Soc       Date:  2002-11       Impact factor: 2.892

9.  Age-related mild cognitive deficit: a ready-to-use concept?

Authors:  Christian Gilles
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

10.  Magnetic resonance spectroscopy in Alzheimer's disease.

Authors:  Jonathan Graff-Radford; Kejal Kantarci
Journal:  Neuropsychiatr Dis Treat       Date:  2013-05-16       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.